| Value | ₹8.19 Cr |
|---|
BSE filing, NSE: VENMAX. Summary written from the filing by ALFA Finder's alert engine.
Venmax Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹13.06
- Market cap
- ₹11.47 Cr
- Revenue (annual)
- ₹8.02 Cr
- Net profit (annual)
- ₹0.25 Cr
- P/E (TTM)
- 40.9×Sector 46.1×
- Promoter holding
- 10.46%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venmax Drugs & Pharmaceuticals Ltd
All →Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs' shareholders met on 24 October 2026 under an NCLT order to approve an amalgamation with Hatri Pharma. Voting results await the scrutinizer's report.
Venmax Drugs & Pharmaceuticals Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Venmax Drugs & Pharmaceuticals Annual General Meeting
Venmax Drugs and Pharmaceuticals held its 37th Annual General Meeting on September 26, 2026. Shareholders considered the financial statements and various directorship appointments.
Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs and Pharmaceuticals Limited announced an NCLT-convened meeting of equity shareholders on October 24, 2026, to consider the proposed merger with Hatri Pharma Private Limited.
Venmax Drugs & Pharmaceuticals Acquisition
NCLT Hyderabad directed Venmax to convene a shareholder meeting on 24 Oct 2026 for the amalgamation of Hatri Pharma into Venmax. The order also dispensed with meetings of Hatri Pharma's shareholders and creditors.
Venmax Drugs & Pharmaceuticals Annual Report
Venmax Drugs and Pharmaceuticals Limited has submitted its Annual Report for the Financial Year 2025-26, including the Notice for its 37th Annual General Meeting.
Other financial results announcements
All →Vaibhav Global Q2 FY27 Results: Net Profit ₹41.7 Cr, Down 12.4% YoY
Vaibhav Global Ltd reported revenue from operations of ₹938.4 Cr (+7.0% YoY) and net profit of ₹41.7 Cr (-12.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹41.7 Cr · -12.4% YoY
MosChip Technologies Q2 FY27 Results: Net Loss of ₹30.4 Cr
MosChip Technologies Ltd reported revenue from operations of ₹119.1 Cr (-18.9% YoY) and a net loss of ₹30.4 Cr for Q2 FY27.
- Key figure
- Net loss ₹30.4 Cr
OnMobile Global Q2 FY27 Results: Net Loss of ₹10.5 Cr
OnMobile Global Ltd reported revenue from operations of ₹127.1 Cr (-0.9% YoY) and a net loss of ₹10.5 Cr for Q2 FY27.
- Key figure
- Net loss ₹10.5 Cr
Zensar Technologies Q2 FY27 Results: Net Profit ₹190.2 Cr, Up 4.4% YoY
Zensar Technologies Ltd reported revenue from operations of ₹1,585 Cr (+11.5% YoY) and net profit of ₹190.2 Cr (+4.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹190.2 Cr · +4.4% YoY
GMR Airports Q2 FY27 Results: Net Profit ₹65.4 Cr, Up 86.3% YoY
GMR Airports Ltd reported revenue from operations of ₹4,095 Cr (+11.6% YoY) and net profit of ₹65.4 Cr (+86.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹65.4 Cr · +86.3% YoY
Hexaware Technologies Q2 FY27 Results: Net Profit ₹429.4 Cr, Up 16.1% YoY
Hexaware Technologies Ltd reported revenue from operations of ₹3,933 Cr (+12.9% YoY) and net profit of ₹429.4 Cr (+16.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹429.4 Cr · +16.1% YoY